04 Oct Participate in Research!
PROACTIVE CELIAC STUDY: The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015. In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused by accidental gluten exposure. Requirements: 18-70 years old Biopsy-confirmed celiac disease On a...